China CAR T-Cell Therapy Market: Autologous Leads While Allogeneic...

added blog Health

2026-09-03 09:09:21 -

China CAR T-Cell Therapy Market: Autologous Leads While Allogeneic Gains Rapid Traction

The [China CAR T-Cell Therapy Market] is characterized by a diverse range of cell sources, each with distinct advantages and challenges. According to Market Research Future, autologous CAR T-cell therapies currently hold the largest market share, leveraging T-cells derived from the patient's own body. This personalized approach ensures high efficacy and a lower risk of adverse...

0 Comments 0 Shares 100 Views 0 Reviews